MacroGenics Common Stock Total Equity from 2010 to 2024
| MGNX Stock | USD 3.29 0.05 1.54% |
Common Stock Total Equity | First Reported 2012-12-31 | Previous Quarter 618 K | Current Value 619 K | Quarterly Volatility 157.3 K |
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
MacroGenics | Common Stock Total Equity |
Latest MacroGenics' Common Stock Total Equity Growth Pattern
Below is the plot of the Common Stock Total Equity of MacroGenics over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. MacroGenics' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
| Common Stock Total Equity | 10 Years Trend |
|
Common Stock Total Equity |
| Timeline |
MacroGenics Common Stock Total Equity Regression Statistics
| Arithmetic Mean | 362,421 | |
| Geometric Mean | 204,788 | |
| Coefficient Of Variation | 61.70 | |
| Mean Deviation | 170,827 | |
| Median | 369,000 | |
| Standard Deviation | 223,604 | |
| Sample Variance | 50B | |
| Range | 699.1K | |
| R-Value | 0.90 | |
| Mean Square Error | 10.3B | |
| R-Squared | 0.81 | |
| Slope | 44,939 | |
| Total Sum of Squares | 700B |
MacroGenics Common Stock Total Equity History
About MacroGenics Financial Statements
MacroGenics investors use historical fundamental indicators, such as MacroGenics' Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Total Equity | 709.5 K | 396 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.